Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo
Number of days of treatment with opioid analgesics · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in number of days of treatment with opioid analgesics compared with placebo; GRADE not reported.
1 finding from 1 review
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesBMT/SCT after conditioning for haematological cancersMD -1.41 [-3.33, 0.51]2 studies · 323 participantsGRADE not reported